Showing results (71-80 of 81) with videos related to
Sort By:
Pageof 9
Infectious Agents and Cancer|April 6, 2018
Immunogenicity of a Fap2 peptide mimotope of Fusobacterium nucleatum and its potential use in the diagnosis of colorectal cancerLeonardo A Guevarra, Andrea Claudine F Afable, Patricia Joyce O Belza, et al.Journal of Medicinal Chemistry|January 17, 2014
Structure-based design of new dihydrofolate reductase antibacterial agents: 7-(benzimidazol-1-yl)-2,4-diaminoquinazolinesThanh Lam, Mark T Hilgers, Mark L Cunningham, et al.Acta Medica Philippina|August 14, 2025
Health System Responsiveness of Rural Health Units in the Cagayan Valley Region: A Cross-sectional StudyJonalyn P Santos, Janina C Abad, Alvin A Aldea, et al.Contemporary Clinical Trials|November 8, 2015
A randomised trial comparing low-fat diets differing in carbohydrate and protein ratio, combined with regular moderate intensity exercise, on glycaemic control, cardiometabolic risk factors, food cravings, cognitive function and psychological wellbeing in adults with type 2 diabetes: Study protocolNerylee Ann Watson, Kathryn Ann Dyer, Jonathan David Buckley, et al.Antimicrobial Agents and Chemotherapy|June 13, 2018
In Vitro and In Vivo Evaluation of APX001A/APX001 and Other Gwt1 Inhibitors against CryptococcusKaren Joy Shaw, Wiley A Schell, Jonathan Covel, et al.The Journal of Antibiotics|April 17, 2014
Anthracimycin activity against contemporary methicillin-resistant Staphylococcus aureusMary E Hensler, Kyoung Hwa Jang, Wdee Thienphrapa, et al.Antimicrobial Agents and Chemotherapy|December 24, 2004
Identification of novel inhibitors of bacterial translation elongation factorsMaithri M K Jayasekera, Keysha Onheiber, John Keith, et al.Bioorganic & Medicinal Chemistry Letters|March 21, 2007
Novel pyrazole derivatives as potent inhibitors of type II topoisomerases. Part 1: synthesis and preliminary SAR analysisLaurent Gomez, Michael D Hack, Jiejun Wu, et al.Clinical Rheumatology|January 13, 2023
Outcomes of Filipinos with inflammatory rheumatic diseases developing COVID-19 prior to vaccinations and new variants: a historical perspectiveGeraldine Tong Zamora-Abrahan, Evelyn Osio Salido, Juan Javier Tayengco Lichauco, et al.Bioorganic & Medicinal Chemistry Letters|March 27, 2007
Tetrahydroindazole inhibitors of bacterial type II topoisomerases. Part 2: SAR development and potency against multidrug-resistant strainsJohn J M Wiener, Laurent Gomez, Hariharan Venkatesan, et al.Pageof 9